Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-R Burmester

Showing results (121-130 of 293) with videos related to

Pageof 30
Sort By:
European Journal of Immunology|November 13, 2019
Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodiesQingyu Cheng, Andreas Pelz, Adriano Taddeo, et al.
Arthritis Research & Therapy|June 12, 2020
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studiesMark C Genovese, Roy Fleischmann, Alan Kivitz, et al.
RMD Open|January 27, 2017
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndromeThomas Rose, Franziska Szelinski, Anna Lisney, et al.
Annals of the Rheumatic Diseases|September 8, 2012
The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapyTina M Backhaus, Sarah Ohrndorf, Herbert Kellner, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis Research & Therapy|July 21, 2009
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patientsKatrin Schmidt, Lorena Martinez-Gamboa, Susan Meier, et al.
Plos One|August 8, 2014
Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓKhetam Ghannam, Lorena Martinez-Gamboa, Lydia Spengler, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Treatment of relapsing polychondritis: a systematic reviewArthur Petitdemange, Cédric Sztejkowski, Laura Damian, et al.
The Journal of Rheumatology|October 17, 2009
Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndromeLars Morawietz, Lorena Martinez-Gamboa, Sonja Scheffler, et al.
Arthritis and Rheumatism|March 8, 2005
A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritisAlexander K Scheel, Kay-Geert A Hermann, Elke Kahler, et al.
Pageof 30

Showing results (121-130 of 293) with videos related to

Sort By:
Pageof 30
European Journal of Immunology|November 13, 2019
Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodiesQingyu Cheng, Andreas Pelz, Adriano Taddeo, et al.
Arthritis Research & Therapy|June 12, 2020
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studiesMark C Genovese, Roy Fleischmann, Alan Kivitz, et al.
RMD Open|January 27, 2017
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndromeThomas Rose, Franziska Szelinski, Anna Lisney, et al.
Annals of the Rheumatic Diseases|September 8, 2012
The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapyTina M Backhaus, Sarah Ohrndorf, Herbert Kellner, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis Research & Therapy|July 21, 2009
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patientsKatrin Schmidt, Lorena Martinez-Gamboa, Susan Meier, et al.
Plos One|August 8, 2014
Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓKhetam Ghannam, Lorena Martinez-Gamboa, Lydia Spengler, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Treatment of relapsing polychondritis: a systematic reviewArthur Petitdemange, Cédric Sztejkowski, Laura Damian, et al.
The Journal of Rheumatology|October 17, 2009
Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndromeLars Morawietz, Lorena Martinez-Gamboa, Sonja Scheffler, et al.
Arthritis and Rheumatism|March 8, 2005
A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritisAlexander K Scheel, Kay-Geert A Hermann, Elke Kahler, et al.
Pageof 30